SEATTLE, August 02, 2021, (MEDGADGET) — Global Oxytocic Pharmaceuticals Market – Insights
To induce uterine development, oxytocic drugs are used. It’s also used to stop bleeding after a baby is born. It’s either injected into a muscle or given as a vein infusion. Natural oxytocin is made by removing it from an animal’s pituitary gland.
The global oxytocic pharmaceuticals market’s Postpartum Hemorrhage segment was worth US$ 62.7 million in 2019 and is projected to grow at a CAGR of 10.2 percent to US$ 136.2 million by 2027.
Get an exclusive sample copy of the business report: https://www.coherentmarketinsights.com/insight/request-sample/3354
Drivers:
The global oxytocic pharmaceuticals market is projected to rise due to an increase in childbirths using labor induction. According to a January 2019 study from the National Perinatal Information Center, induction of labor rates in the United States rose by 40% from 1997 to 2017.
Furthermore, an increase in the prevalence of postpartum hemorrhage is expected to boost market growth. According to the report, “Incidence and risk factors for postpartum hemorrhage among transvaginal deliveries at a tertiary perinatal medical facility in Japan,” reported in the journal PLoS One in January 2019, the rate of postpartum hemorrhage was 8.7%, and the rate of serious postpartum hemorrhage was 2.1%.
In terms of value, the Asia Pacific region dominated the global oxytocic pharmaceuticals market in 2019, accounting for 58.1 percent of the market, followed by 2027.
Restraints:
The global oxytocic pharmaceuticals market is projected to be hampered by the availability of alternative drugs. Misoprostol and magnesium sulphates are two oxytocic pharmaceutical alternatives. Misoprostol is a low-cost, evidence-based alternative to oxytocin, according to the World Health Organization.
Furthermore, problems associated with oxytocin preparations are likely to hinder market development. Several manufacturers have failed to obtain WHO prequalification for the manufacture of oxytocin products, resulting in the production of drugs of poor quality on the market.
“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3354
Opportunities:
Growing focus of accomplishing mortality ratio of under 70 for each 100 000 live births in under-resourced areas is required to offer worthwhile development openings for major parts on the lookout. For example, as indicated by Maternal Mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division, Sub-Saharan Africa recorded the most noteworthy proportion or maternal mortality, at 555 for every 100, 000 live births, from 1990 to 2015. Also, the United Nations is centered around accomplishing the Sustainable Development Goals 2015 – 2030 worldwide maternal mortality ratio focus of under 70 for each 100 000 live births.
Furthermore, research and development into the use of oxytocin at lower doses after a caesarean section is expected to increase demand for oxytocin pharmaceuticals.
Market Trends/Key Takeaways:
For goods to be supplied to foreign organizations, market players need WHO prequalification. Manufacturers who follow the WHO’s prequalification guidelines may have a better chance of gaining market share than those who do not.
In Latin America, rising teen pregnancies are projected to result in high demand for oxytocic for labor or abortion. According to the Pan American Health Organization (PAHO), the United Nations Children’s Fund (UNICEF), and the United Nations Population Fund (UNFPA), there were 66.5 births per 1,000 girls aged 15 to 19 in Latin America from 2010 to 2015, compared to 46 births per 1,000 girls in the same age group worldwide.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/oxytocic-pharmaceuticals-market-2720
Key Development:
In July 2019, Carboprost Tromethamine Injection USP, 250mcg/mL (1mL), a standardized form of Hemabate, was introduced by Dr. Reddy’s Laboratories (Pfizer).
In May 2018, Granules Pharmaceuticals, Inc., a wholly-owned subsidiary of Granules India Ltd., teamed up with West-Ward Pharmaceuticals Corp., a wholly-owned subsidiary of Hikma Pharmaceuticals PLC, to launch the generic version of Methylergonovine Maleate Tablets, USP, 0.2mg, the generic counterpart of Methergine.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- Regulatory Scenario
- PEST Analysis
- Mergers and Acquisitions
- Market Dynamics
- Global Oxytocic Pharmaceuticals Market, By Indication, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Synthetic Oxytocin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Oxytocic Pharmaceuticals Market, By End User, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Maternity Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Oxytocic Pharmaceuticals Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Source of Origin, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Other Exclusive Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837